FulcrumTx
Edit

FulcrumTx

https://www.fulcrumtx.com/
Last activity: 12.05.2026
Active
Categories: BioTechCauseCultureDrugFutureHealthTechITLearnScienceTools
Our approach to drug discovery generates significant insights into disease biology and allows us to think creatively about the best way to modulate and balance gene expression. Our initial areas of focus are facioscapulohumeral muscular dystrophy (FSHD), sickle cell disease (SCD) and beta thalassemia.

We take great pride in being purposeful patient partners who do this work, not just for patients, but with patients. We have a culture of trust and transparency which enables our employees to focus on our mission and the science behind it. In addition, we are invested in our people and want to ensure they have the tools and training they need to succeed. This allows our playful spirit to come alive, making work more enjoyable for our entire #Fulcrew.

Learn more about who we are at https://www.fulcrumtx.com/
Likes
93
Mentions
27
Location: United States, Massachusetts, Cambridge
Employees: 51-200
Total raised: $135M
Founded date: 2016

Investors 5

Funding Rounds 2

DateSeriesAmountInvestors
05.09.2018Series B$80M-
21.07.2016Series A$55M-

Mentions in press and media 27

DateTitleDescription
12.05.2026AstronauTx builds executive team with appointment of experienced clinical development leader Michelle Mellion, MD as Chief Medical OfficerLondon, UK, 12 May 2026 – AstronauTx Ltd (“AstronauTx”), a biotechnology company developing therapeutics to treat Alzheimer’s Disease and other neurological disorders by improving sleep architecture, announces the appointments of Dr. Michel...
26.09.2024Pfizer's Oxbryta exit may hasten trials of rival experimental sickle cell drugs, analysts sayFuture of HealthRegulatory Oversight Commercial Strategy Regulatory Pfizer's Oxbryta exit may hasten trials of rival experimental sickle cell drugs, analysts say By Kashish Tandon and Christy SanthoshSeptember 26, 20243:40 PM UTCUpdated ago...
27.08.20243 High-Potential Biotech Stocks Under $10 The biotech industry is witnessing rapid growth owing to its increasing demand and the inclusion of technological advancements. In this wake, investors could ...The biotech industry is witnessing rapid growth owing to its increasing demand and the inclusion of technological advancements. In this wake, investors could consider adding pocket-friendly biotech stocks Fulcrum Therapeutics (FULC), BioCry...
30.07.2024BioIVT Appoints Dr. Judith Dunn and Dr. Auro Nair to its Board of DirectorsWESTBURY, N.Y., July 30, 2024 /PRNewswire/ -- BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, today announced the appointment of Dr. Judith Dunn and Dr. Auro Nair to its Board of Dir...
08.03.2024Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)CAMBRIDGE, Mass., March 08, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare...
08.03.2024Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)-
05.03.2024Fulcrum Therapeutics to Participate at the Leerink Partners Global Biopharma Conference-
23.05.202319 Tips To Stay Motivated And Resilient After A Job Lossgetty
17.11.2022Nine Effective Steps For Leaders To Establish Company ValuesCompany values help identify what companies stand for and help bring in like-minded customers and employees who believe in the same values. To establish values, companies must take steps like consulting everyone in the organization and crea...
16.06.202214 Smart Ways To Streamline Your Daily HR Workflow For EfficiencyAs an HR professional, you’re in charge of managing employees throughout their entire cycle with a company. It’s a lot of responsibility that requires an efficient and well-organized person to handle the job. By streamlining your daily work...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In